Edens and Levy, http://www.jcb.org/cgi/content/full/jcb.201406004/DC1 Figure S1 . Nuclear shrinking does not depend on the cytoskeleton or nuclear export, but does depend on a heat-sensitive activity present in embryo extracts. (A) Nuclear shrinking is not dependent on microtubules or filamentous actin. The nuclear shrinking assay was performed as described in Fig. 1 using LEE. Nuclei were visualized by immunofluorescence using mAb414, and cross-sectional nuclear area was measured and normalized against the HI-LEE control. LEE was treated with cytochalasin D (473 µM) to inhibit actin polymerization or nocodazole (33 nM) to inhibit microtubule polymerization. n = 3 different extracts. Student's t test was performed relative to the control. ***, P < 0.005. Error bars represent SD. (B) Nuclear shrinking depends on a heat-sensitive activity in embryo extracts. Nuclei assembled in egg extract were resuspended in extract buffer, HI-LEE, LEE, or egg extract, and incubated for 90 min. Because nuclear size was similar after treatment with buffer or HI-LEE, we felt confident that these controls could be used interchangeably, although we favored the HI-LEE control for being compositionally similar to the LEE. n = 4 different extracts. Student's t test was performed relative to the buffer control. ***, P < 0.005. Error bars represent SD. (C) PKC protein levels remain constant during early X. laevis development. Whole X. laevis embryo lysates were prepared from stages 2-12. For each stage, 0.6 embryo equivalents were separated on a 10% SDS-PAGE gel, transferred to PVDF, and probed with antibodies against pan-PKC and Ran (for normalization). ImageJ was used to quantify PKC and Ran band intensities. For each stage, PKC levels were normalized to Ran levels, which remain constant throughout early development (Levy and Heald, 2010). Each stage was then normalized against stage 2. Means are shown from two different sets of whole embryo preparations. Error bars represent SD. (D) Blocking nuclear export does not affect nuclear size in vivo in the early embryo. As nuclear import has been implicated in the regulation of nuclear size (Levy and Heald, 2010), we tested if changes in nucleocytoplasmic transport might account for reductions in nuclear size in the post-MBT embryo. Different stage X. laevis embryos were treated with leptomycin B, added at 1 µg/ml to the culture medium, for 90 min at room temperature. Leptomycin B is a specific inhibitor of CRM1-mediated nuclear export. Nuclei were isolated from embryos, fixed, spun onto coverslips, and visualized by immunofluorescence with mAb414. Cross-sectional nuclear area was measured for at least 110 nuclei per condition. Error bars represent SE. One representative experiment out of three is shown. Treatment of X. laevis embryos with leptomycin B did not alter nuclear size, even though blocking nuclear export increased bulk nuclear import, as monitored with a GFP-NLS reporter construct (not depicted). These data suggest that altered nucleocytoplasmic transport does not contribute to reduced nuclear size in the post-MBT embryo.
. Increased nuclear PKC localization during shrinking is associated with removal of lamins but not NPCs. (A and B) NPC and LB3 quantification from wide-field microscopy images. The nuclear shrinking assay was performed as described in Fig. 2 B, and nuclei were visualized with mAb414 (red) and LB3 (green) antibodies. Nuclei were visualized by wide-field microscopy, and images were acquired with the same exposure time for a given staining. Intensity measurements were performed on whole nuclei to estimate total staining per nucleus. Density measurements were estimated by dividing total staining intensity by nuclear surface area. For NPC staining, data from one representative experiment of three are shown, and error bars indicate SE. For LB3 staining, n = 3 different extracts, and error bars indicate SD. ***, P < 0.005; *, P < 0.05. (C and D) Nuclear PKC staining increases upon nuclear shrinking. The nuclear shrinking assay was performed as in Fig. 1 . Nuclei were stained with Hoechst (blue) and visualized with mAb414 (red) and pan-PKC (green) antibodies. For a given staining, wide-field microscopy images were acquired with the same exposure time. PKC staining intensity per nucleus was quantified and normalized to the buffer control. n = 3 different extracts. ***, P < 0.005. Error bars represent SE. (E and F) Nuclear cPKC staining is greater in stage 12 nuclei than in de novo assembled nuclei. Nuclei assembled de novo in egg extract and endogenous stage 12 nuclei were stained with a phospho-cPKC antibody (green), and wide-field microscopy images were acquired with the same exposure time. PKC staining intensity per nucleus was quantified and normalized against nuclei assembled in egg extract. n = 2 different extracts. **, P < 0.01. Error bars represent SD. (G) PKC morpholino injections deplete PKC levels. Western blots were performed as in Fig. S1 C with morpholino-injected embryo lysates, probed with the pan-PKC antibody. (H) PKC depletion by morpholino injection increases nuclear size in embryos. One-cell embryos were microinjected with morpholinos against PKC , PKC , or a scrambled control and allowed to develop to stage 12. Nuclei isolated from embryos were visualized with mAb414. Bars: (A) 20 µm; (C, E, and H) 10 µm. Figure S3 . Equilibrium balance model of steady-state nuclear size regulation. In the pre-MBT embryo, nuclear growth is mediated by greater importin  activity and import of LB3. In the post-MBT embryo, nuclear shrinking is mediated by increased nuclear cPKC localization and activity, and subsequent dissociation of lamins from the NE. A balance of import and cPKC-mediated shrinking determines steady-state nuclear size. Video 1. Time-lapse imaging of nuclei resizing in the nuclear shrinking assay. Nuclei were assembled de novo in X. laevis egg extract supplemented with recombinant GFP-LB3. These nuclei were isolated and incubated in LEE, as described in the Materials and methods under "Nuclear shrinking assay." Images were acquired using a wide-field epifluorescence microscope (BX51; Olympus). Live time-lapse imaging of GFP-LB3 was performed at 30-s intervals for 90 min, and the final movie was compressed into 30 frames per second with ImageJ.
Video 2. Time-lapse imaging of control stage 12 embryos. Single-cell embryos were microinjected with GFP-NLS mRNA and allowed to develop to stage 12. Embryos were placed in a glass-bottom Petri dish in 1/3× MMR. Time-lapse confocal imaging of live embryos was performed, visualizing nuclei labeled with GFP-NLS. Using MetaMorph software, time-lapse confocal images were acquired every minute for 45 min using a spinning-disk confocal microscope (IX71 [Olympus] equipped with a CSU-X1 spinning-disk head [Yokogawa Electric Corporation] Video 6. Time-lapse imaging of chelerythrine-treated stage 12 embryos. Single-cell embryos were microinjected with GFP-NLS mRNA and allowed to develop to stage 12. Embryos were placed in a glass-bottom Petri dish in 1/3× MMR supplemented with 24 µM chelerythrine. Time-lapse confocal imaging of live embryos was performed, visualizing nuclei labeled with GFP-NLS. Using MetaMorph software, time-lapse confocal images were acquired every minute for 45 min using a spinning-disk confocal microscope (IX71 [Olympus] equipped with a CSU-X1 spinning-disk head [Yokogawa Electric Corporation] ). Time lapses were compressed into 15 frames per second with ImageJ. Bars, 100 µm.
Video 7. Time-lapse imaging of chelerythrine-treated stage 12 embryos. Single-cell embryos were microinjected with GFP-NLS mRNA and allowed to develop to stage 12. Embryos were placed in a glass bottom Petri dish in 1/3× MMR supplemented with 24 µM chelerythrine. Time-lapse confocal imaging of live embryos was performed, visualizing nuclei labeled with GFP-NLS. Using MetaMorph software, time-lapse confocal images were acquired every minute for 45 min using a spinning-disk confocal microscope (IX71 [Olympus] equipped with a CSU-X1 spinning-disk head [Yokogawa Electric Corporation] ). Time lapses were compressed into 15 frames per second with ImageJ. Bar, 100 µm.
Video 8. Time-lapse imaging of PMA-treated stage 12 embryos. Single-cell embryos were microinjected with GFP-NLS mRNA and allowed to develop to stage 12. Embryos were placed in a glass-bottom Petri dish in 1/3× MMR supplemented with 80 nM PMA. Time-lapse confocal imaging of live embryos was performed, visualizing nuclei labeled with GFP-NLS. Using MetaMorph software, time-lapse confocal images were acquired every minute for 45 min using a spinning-disk confocal microscope (IX71 [Olympus] equipped with a CSU-X1 spinning-disk head [Yokogawa Electric Corporation] 
